NPC Comments on Appointment of AHRQ Director

Washington, DC, August 19, 2013—National Pharmaceutical Council (NPC) President Dan Leonard today released the following statement about the appointment of Richard Kronick, PhD, as the new director of the Agency for Healthcare Research and Quality (AHRQ):

“Dr. Kronick joins AHRQ at a time of significant investment and interest in comparative effectiveness research. AHRQ has an important role in this effort because it is tasked with translating and disseminating all of the research generated by the Patient-Centered Outcomes Research Institute grants.

“Done well, these efforts can help to get the right information into the hands of health care decision-makers and help to improve patient health outcomes.

“We wish Dr. Kronick well in his new role at AHRQ and look forward to working with him in tackling these challenges.”

About the National Pharmaceutical Council

The National Pharmaceutical Council is a health policy research organization dedicated to the advancement of good evidence and science, and to fostering an environment in the United States that supports medical innovation. Founded in 1953 and supported by the nation’s major research-based pharmaceutical companies, NPC focuses on research development, information dissemination, and education on the critical issues of evidence, innovation and the value of medicines for patients. For more information, visit www.npcnow.org and follow NPC on Twitter @npcnow.
# # #